Table 6.
Infants (12 weeks–11 months) | Toddlers (12–35 months) | Children (3–9 years) | Adolescents (10–17 years) | Adults (18–64 years) | The elderly (≥ 65 years) | |
---|---|---|---|---|---|---|
Regulatory maximum level exposure assessment scenario | ||||||
Mean | 18.5–74.2 | 18.5–39.4 | 10.2–31.2 | 7.0–18.5 | 4.9–13.2 | 3.9–10.1 |
95th percentile | 43.6–162.7 | 38.2–71.9 | 25.0–79.2 | 16.3–36.0 | 10.6–29.9 | 8.4–23.7 |
Refined estimated exposure assessment scenario | ||||||
Brand‐loyal scenario | ||||||
Mean | 2.8–11.0 | 9.0–18.9 | 5.9–24.5 | 4.1–9.9 | 2.8–8.0 | 2.3–6.5 |
95th percentile | 10.6–26.4 | 16.9–44.6 | 14.7–61.0 | 9.6–21.3 | 5.6–18.8 | 4.3–16.7 |
Non‐brand‐loyal scenario | ||||||
Mean | 0.8–5.3 | 3.0–7.4 | 2.7–18.4 | 1.7–4.1 | 0.9–2.7 | 0.7–2.6 |
95th percentile | 3.4–13.6 | 7.7–14.9 | 5.6–49.7 | 3.9–8.9 | 2.3–6.4 | 1.7–5.6 |